TrialClinical pharmacology in drug development2018

Cardiac Safety of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator: Results of a Thorough QT/QTc Study.

Jonathan Q Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.